stock repurchase 4basebio Announces Treasury Share Buyback The company recently changed its name from Expedeon following the sale of its immunology and proteomics businesses to Abcam. Bruker Authorizes $300M Share Repurchase Program The company also announced that its board of directors has authorized payment of a quarterly cash dividend of $0.04 per share of its common stock. Qiagen Q1 Revenues Grow 2 Percent Qiagen also announced plans to launch a new $100 million share repurchase program after completing its current $200 million share repurchase commitment. Myriad Genetics to Repurchase $50M in Shares From Bank of America The company has entered into an accelerated share repurchase program with the bank to buy back a portion of its common stock. Thermo Fisher to Repurchase $2B of its Shares, Acquire BD's Advanced Bioprocessing Business The BD business, which has annual revenues of about $100 million, offers technical services as well as peptones for cell culture media used in biopharmaceutical applications. Nov 28, 2017 Bio-Rad Authorizes $250M Share Repurchase Program Jan 18, 2017 Qiagen Details $250M Synthetic Share Repurchase Plan Aug 15, 2016 Qiagen Announces $250M Synthetic Share Repurchase Program Aug 4, 2016 PerkinElmer Q2 Revenues Up 2 Percent; Discloses Bioo Scientific Acquisition Jun 7, 2016 Myriad Genetics Adds $200M to Share Repurchase Program Nov 13, 2015 Thermo Fisher Announces $1B Share Repurchase Plan Nov 13, 2015 Bruker Board OKs $225M Share Repurchase Program Nov 2, 2015 Illumina Launches $250M Share Repurchase Program May 28, 2015 Agilent Board Approves $1.14B Share Buyback Program May 22, 2015 Bruker Authorizes Share Buyback Program May 13, 2015 Qiagen Repurchasing up to $30M of Shares Feb 24, 2015 Myriad Board OKs $200M Share Repurchase Program Aug 6, 2014 Waters Discloses $23M Price Tag for MediMass Technology; New Share Buyback Program Approved Nov 22, 2013 Agilent Board Authorizes Share Repurchase Program, Dividend Sep 12, 2013 Qiagen Initiates Buyback of $10M of Shares Jul 31, 2013 UPDATE: Qiagen Revenues up 3 Percent in Q2; Plans $100M Stock Buyback Apr 23, 2013 Quest Enters into Agreement to Buy Back $450M of Stock Jan 17, 2013 Agilent to Undertake $500M Share Repurchase, Increases Dividend Dec 11, 2012 Genomic Health's Board Approves $30M Share Repurchase Program Sep 24, 2012 Qiagen Initiating First Tranche of Share Buyback Program; Repurchasing $10M of Shares Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.